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Le bloc interscalénique du plexus brachial avec injection extrafasciale reduit les 
complications respiratoires comparé à l’injection intrafasciale conventionnelle: 
étude randomisée, en double aveugle et controlée. 
Introduction : Les avantages de l’anesthésie locorégionale ont été bien documentés et incluent une 
diminution de la morbidité et de la mortalité, une meilleure analgésie postopératoire, une meilleure 
efficience des coûts, ainsi qu’un taux réduit de complications graves. En effet, l’anesthésie 
locorégionale échoguidée par ultrasons permet de procéder à une anesthésie fiable et uniforme autour 
de la cible nerveuse avec une installation du bloc nerveux plus rapide, de plus longue durée et de 
meilleure qualité tout en diminuant les risques d’injection intra vasculaire et de traumatisme nerveux.  
Le bloc interscalénique consiste à placer une aiguille dans le plexus brachial (approche intrafasciale 
conventionnelle) par le sillon interscalénique, constitué des muscles scalènes antérieur et moyen, afin 
de permettre la diffusion de l’anesthésique local au sein des racines nerveuses du plexus brachial. 
Cette technique permet d’assurer une analgésie puissante et localisée durant les jours suivants une 
chirurgie majeure de l'épaule. Néanmoins, le principal effet secondaire de cette procédure est la 
parésie de l’hémi diaphragme ipsilatéral, principal muscle respiratoire, qui peut atteindre 90 à 100 % 
des cas et qui est due à l’extension de l'anesthésique local au nerf phrénique cheminant en avant du 
plexus brachial. Dès lors, cette procédure devient contre-indiquée chez les patients souffrant 
d’insuffisance respiratoire sévère et de facto, les excluant des bénéfices liés à cette anesthésie 
locorégionale. L’hypothèse de cette étude randomisée, en double aveugle et contrôlée sur le bloc 
interscalénique échoguidé est de démontrer que l’injection extrafasciale (approche latérale, à distance 
de 4 mm de la gaine du plexus brachial) permet d’obtenir moins de complications respiratoires qu’avec 
l’injection intrafasciale tout en bénéficiant d’une analgésie équivalente. 
Méthode : Quarante patients ASA I-III adressés pour une chirurgie majeure de l’épaule sous 
anesthésie générale ont été randomisés en deux groupes ; le premier groupe a bénéficié d’une 
analgésie par un bloc interscalénique échoguidé avec une injection intrafasciale tandis que le second 
groupe a bénéficié d’un bloc interscalénique échoguidé avec une injection extrafasciale. Tous les 
patients ont reçu la même dose d’anesthésique local (20 ml de bupivacaine 0.5% avec adrénaline 
1:200 000). L’objectif primaire de cette étude est l’incidence de parésie hémi diaphragmatique, définie 
comme une réduction de > 75% de l’excursion diaphragmatique. Les mouvements diaphragmatiques 
ont été évalués par échographie en M-mode avant la chirurgie (fonction de base) et 30 minutes après 
la procédure. Les objectifs secondaires sont la capacité vitale forcée (CVF), le volume expiratoire 
maximum en 1 seconde (VEMS) et le débit expiratoire de pointe (DEP). Les objectifs additionnels 
incluent le délai avant la première administration d’opiacé et l’évaluation de la douleur à 24h (échelle 
numérique de la douleur, de 0 à 10).  
Résultats : L’incidence de la parésie hémi diaphragmatique était de 90% (95% CI: 68–99%) pour le 
groupe ayant bénéficié d’une injection intrafasciale et de 21% (95% CI: 6–46%) pour le groupe ayant 
bénéficié d’une injection extrafasciale (P<0.0001). De plus, concernant les objectifs secondaires le 
groupe extrafasciale a montré une meilleure préservation des fonctions respiratoires. Le temps moyen 
avant l’administration du premier opiacé est similaire dans les deux groupes (intrafasciale: 802 min 
[95% CI: 620–984 min]; extrafasciale: 973 min [95% CI: 791–1155 min]; P=0.19), de même que le 
évaluation de la douleur à 24h (intrafasciale: 1.6 [95% CI: 0.9–2.2]; extrafasciale: 1.6 [95% CI: 0.8–
2.4]; P=0.97).  
Conclusion : Le bloc interscalénique échoguidé du plexus brachial avec une injection extrafasciale 
réduit l'incidence de la parésie hémi-diaphragmatique et l'impact sur la fonction respiratoire tout en 
offrant une analgésie similaire par rapport à l’approche conventionnelle. 
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Extrafascial injection for interscalene brachial plexus
block reduces respiratory complications compared with
a conventional intrafascial injection: a randomized,
controlled, double-blind trial†
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and E. Albrecht1,*
1Department of Anaesthesia, 2Department of Orthopaedic, Lausanne University Hospital, Lausanne,
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University of Toronto, Toronto, Canada
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Abstract
Background: Hemidiaphragmatic paresis after ultrasound-guided interscalene brachial plexus block is reported to occur in up
to 100% of patients. We tested the hypothesis that an injection lateral to the brachial plexus sheath reduces the incidence of
hemidiaphragmatic paresis compared with a conventional intrafascial injection, while providing similar analgesia.
Methods: Forty ASA I-III patients undergoing elective shoulder and clavicle surgery under general anaesthesia were
randomized to receive anultrasound-guided interscalene brachial plexus block for analgesia, using 20ml bupivacaine 0.5%with
epinephrine 1:200 000 injected either between C5 and C6within the interscalene groove (conventional intrafascial injection), or
4 mm lateral to the brachial plexus sheath (extrafascial injection). The primary outcome was incidence of hemidiaphragmatic
paresis (diaphragmatic excursion reduction >75%), measured by M-mode ultrasonography, before and 30 min after the
procedure. Secondary outcomeswere forced vital capacity, forced expiratory volume in 1 s, and peak expiratory ﬂow. Additional
outcomes included time to ﬁrst opioid request and pain scores at 24 h postoperatively (numeric rating scale, 0–10).
Results: The incidences of hemidiaphragmatic paresis were 90% (95% CI: 68–99%) and 21% (95% CI: 6–46%) in the conventional
and extrafascial injection groups, respectively (P<0.0001). Other respiratory outcomes were signiﬁcantly better preserved in the
extrafascial injection group. The mean time to ﬁrst opioid request was similar between groups (conventional: 802 min [95% CI:
620–984min]; extrafascial: 973min [95% CI: 791–1155min]; P=0.19) as were pain scores at 24 h postoperatively (conventional: 1.6
[95% CI: 0.9–2.2]; extrafascial: 1.6 [95% CI: 0.8–2.4]; P=0.97).
Conclusions: Ultrasound-guided interscalene brachial plexus block with an extrafascial injection reduces the incidence of
hemidiaphragmatic paresis and impact on respiratory function while providing similar analgesia, when compared with a
conventional injection.
Clinical trial registration: NCT02074397.
Key words: analgesia; anesthesia, regional; brachial plexus block; diaphragm; postoperative pain
† This report was previously presented in part at the annualmeeting of the European Society of Regional Anaesthesia and PainMedicine, Ljubljana, Slovenia,
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Editor’s Key Points
• Hemidiaphragmatic paresis is common after interscalene
brachial plexus block, potentially adversely effecting re-
spiratory function.
• Strategies to reduce this side-effect would improve utility of
the block.
• This prospective study assessed the effect of two different
ultrasound guided approaches on hemidiaphragmatic par-
esis, Extrafascial injection signiﬁcantly reduced hemi-
diaphragmatic paresis and respiratory dysfunction, with
well maintained analgesia.
• This approach warrants further study to clarify its role in
upper limb regional blockade.
Interscalene brachial plexus block (ISB) provides effective anal-
gesia after shoulder surgery1 but causes hemidiaphragmatic par-
esis in up to 100% of patients, because of local anaesthetic spread
to the phrenic nerve traveling along the anteromedial surface of
the anterior scalenemuscle.2 3 This side-effect potentially under-
mines the beneﬁt of regional anaesthesia for patients suffering
from moderate to severe respiratory dysfunction.4 5 Attempts to
reduce the rate of hemidiaphragmatic paresis associated with
ISB have been inconsistent.6–8
Besides hemidiaphragmatic paresis, ISB is also associated
with the highest rate of postoperative neurological deﬁcits in
routine regional anaesthesia practice,9 most likely as a result of
hazardous needle-nerve contact. Indeed, a cadaveric study con-
cluded that difﬁculty with ultrasound discrimination of tissue
layers may contribute to sub-epineurial injection in as many as
50% of conventional intrafascial ISB procedures.10 To explore
the important relationship of needle-nerve proximity in the set-
ting of ISB,we recently demonstrated that depositing local anaes-
thetics as far as 8mm lateral to the brachial plexus sheath during
US-guided ISB, can produce excellent analgesia for shoulder sur-
gery.11 This extrafascial injection lateral to the nerve roots in-
creases the distance to the phrenic nerve and may therefore
reduce the likelihood of its block by the local anaesthetic spread.
In the present randomized controlled double-blinded trial, we
tested the hypothesis that an extrafascial injection can reduce
the rate of hemidiaphragmatic paresis compared with a conven-
tional intrafascial approach, while providing similar analgesia.
Methods
Recruitment and randomization
This trial was approved by the Ethics Committee of the Lausanne
University Hospital (Commission d′Ethique Romande, protocol
number 465/13) and was prospectively registered on clinical-
trials.gov (NCT02074397). All patients aged 18–85 yr undergoing
elective shoulder and clavicle surgery between March and De-
cember 2014 at Lausanne University Hospital, were eligible to
participate in this study. Exclusion criteria included existing
neurological deﬁcit in the upper limb, history of neck surgery or
radiotherapy, moderate to severe pulmonary disease, chest de-
formity, contraindications to peripheral nerve block (e.g. allergy
to local anaesthetics, coagulopathy, infection in the area), and
pregnancy. After providing written informed consent, participat-
ing patients were randomly allocated on the day of surgery to ei-
ther the experimental group (extrafascial injection) or the control
group (conventional injection), using a computer-generated ran-
domization table in aggregates of 10. Assignments were con-
cealed in a sealed opaque envelope.
Interscalene block procedure
All US-guided ISB were performed before surgery in a dedicated
block procedure room. These blocks were achieved or directly su-
pervised by one of the authors (EA) who had no further involve-
ment in the study protocol. Patients were positioned supine with
the head turned 45 degrees to the non-operative side. Electrocar-
diogram, pulse oximetry, and bp monitors were routinely
applied, and oxygen was provided. Peripheral i.v. access was es-
tablished andmidazolam 1–4mg i.v. was administered for anxio-
lysis and sedation as needed. The needle insertion site was
sterilizedwith a solution of chlorhexidine 2% in isopropyl alcohol
70%. Under sterile conditions, a high-frequency linear array
transducer (13–6 MHz, SonoSite S-Nerve; SonoSite, Inc, Bothell,
Washington)was placed over the interscalene region, to visualize
the carotid artery and brachial plexus in the short axis view. The
C5, C6, and C7 roots were identiﬁed in accordance with the de-
scription of Martinoli and colleagues.12 After inﬁltration of the
skin with 1–3 ml of lidocaine 1%, a 22-gauge 50-mm insulated
block needle (SonoPlex Stim cannula, Pajunk®, Geisingen,
Germany) was inserted, in-planewith the US beam on the lateral
side of the transducer. The needle was then advanced under dir-
ect ultrasound guidance through the middle scalene muscle and
toward the lateral border of the brachial plexus sheath. The bra-
chial plexus sheathwas identiﬁed as the linear hyperechoic layer
surrounding the roots of the brachial plexus.
Extrafascial injection group
The ﬁnal needle tip position was 4 mm lateral to the brachial
plexus sheath, at a level equidistant between C5 and C6 roots.
The distance of 4 mm was chosen according to the calculated
success rate over 90% reported recently11 and our daily experi-
ence in a university teaching hospital. The on-screen calliper
measurement tool was used to deﬁne this distance of 4 mm,
with the proximal calliper placed on the lateral border of the
plexus sheath and the distal calliper extended laterally until
the designated distance was reached, marking the target end
point for the needle tip position (Fig. 1).
Conventional injection group
The ﬁnal needle tip position was within the brachial plexus
sheath in between the C5 and C6 nerve roots.
All patients received 20ml of bupivacaine 0.5% with epineph-
rine 1:200 000 through the block needle, injected in 5 ml incre-
ments with intermittent aspiration. No dose adjustments were
made based on patient age. The needle tip was not repositioned,
except if patients complained of paraesthesia.
Intraoperative and postoperative procedure
After application of routine monitors in the operating theatre,
patients received a standard general anaesthetic administered
byananaesthetistwhowas blinded to groupallocation. Anaesthe-
siawas induced using fentanyl 1–2 μg kg−1 i.v. andpropofol 2–4mg
kg−1 i.v. with tracheal intubation facilitated by rocuronium 0.6 mg
kg−1 IV. Maintenance of anaesthesia was via inhaled sevoﬂurane
1.6–2.4% in a 40:60 mixture of oxygen and air. Positive pressure
ventilation was initiated with tidal volume and rate adjusted to
maintain an end-tidal PCO2 of 35–40 mm Hg. Fentanyl 25–50 µg i.v.
was administered asneeded to treat increases in bp or heart rate of
more than 15% above preinduction baseline values. As per our
routine institutional practice, all patients received magnesium
sulphate 50 mg kg−1 i.v.,13 dexamethasone 0.15 mg kg−1 i.v.,14
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ondansetron 4 mg i.v. and droperidol 1 mg i.v. for the purposes of
multimodal analgesia and antiemetic prophylaxis, respectively.
Muscle relaxation was antagonized with neostigmine 50 μg kg−1
and glycopyrrolate 5–10 μg kg−1 at the end of surgery. In phase I re-
covery, pain (numeric rating scale [NRS] ≥4 or patient request for
analgesia) was treated with morphine 1–2 mg every 10 min as
needed. Once oral intake was initiated, patients received acet-
aminophen 1000 mg every 6 h and oxycodone 5 mg per every 3 h
as needed. Antiemetic medications on the ward included ondan-
setron 4 mg i.v. and metoclopramide 10 mg i.v.
Block assessment and deﬁnition of successful block
Assessment of sensory and motor blocks was performed by a
blinded research assistant every 5 min after local anaesthetic in-
jection, for a total duration of 30min. Sensory block was tested in
the C5 and C6 dermatomes using a blunt tip needle pinprick test
(0, no perception; 1, decreased sensation; 2, normal sensation).
Motor block was tested using arm abduction (C5), and forearm
ﬂexion (C6) (incapacity to overcome gravity, 0; reduced force com-
pared with contralateral arm, 1; no loss of force, 2). A successful
block was deﬁned as complete sensory (score, 0) and motor
(score, 0) block in the distribution of the C5 and C6 nerve roots
within 30 min of performing the ISB.
Hemidiaphragmatic excursion and respiratory function
assessment
Hemidiaphragmatic excursion was assessed before and 30 min
after the ISB procedure with a low-frequency curvilinear trans-
ducer (2–5 MHz, SonoSite S-Nerve; SonoSite, Inc, Bothell, Wash-
ington) using a subcostal approach as described previously.15
Brieﬂy, patients were examined in the lying position and the
hemidiaphragm was identiﬁed as an hyperechoic line, with
breathing-related movements using the liver or spleen as an
acoustic window. The hemidiaphragmatic excursion was mea-
sured by real-time M-mode ultrasonography from the resting ex-
piratory position to a deep and quiet inspiration (Supplementary
Appendix 1).
Respiratory function was also assessed before and 30 min
after the regional procedure, with a bedside spirometer (Easy-
One™ Spirometer; ndd Medical Technologies, Andover, UK).
After standard instructions, the patient in a sitting upright pos-
ition was asked to inspire maximally and blow into the device
as fast and strong as possible. The test was repeated three
times and the best value was recorded.
Outcomes
The primary outcome was rate of hemidiaphragmatic paresis
30 min after the procedure, deﬁned as hemidiaphragmatic
excursion reduction superior to 75% compared with the pre-
procedure value.16 17 Secondary outcomes were divided into re-
spiratory-related outcomes, block-related outcomes, and pain-
related outcomes. Respiratory-related outcomes encompassed
rates of forced vital capacity, forced expiratory volume in 1 s,
and peak expiratory ﬂow, all measured 30 min after the injec-
tion. Patients were also asked whether they felt dyspnoeic.
Block-related outcomes included onset times of action of sen-
sory andmotor blocks (deﬁned as time from removal of the nee-
dle until complete loss of sensory and motor function in C5 and
C6 territories); rate of successful block 30min after the injection;
rate of paraesthesia during block performance; rates of Claude-
Bernard-Horner syndrome and hoarseness 30 min after the in-
jection; and durations of sensory block (deﬁned as time from
the injection of local anaesthetic to the time the patient recov-
ered sensation over the shoulder), and motor block (deﬁned as
time from injection of local anaesthetic to the time the patient
could raise their arm). Pain-related outcomes comprised of in-
traoperative fentanyl consumption; time to ﬁrst opioid request
(deﬁned as time from block completion to the time to ﬁrst
dose of i.v. morphine or oxycodone); pain scores (NRS out
of 10) upon admission to Phase 1 recovery and at 24 h post-
operatively; cumulative postoperative opioid consumption
(converted to equivalent doses of i.v. morphine18) in phase 1 re-
covery and at 24 h postoperatively; and satisfaction with overall
anaesthetic management (NRS out of 10). In case of patients
who did not require i.v. morphine or oxycodone during the
ﬁrst 24 postoperative h, time to ﬁrst opioid request was deﬁned
as 1440 min (24 h×60min). As per our routine institutional prac-
tice, all patients were hospitalized overnight and were evalu-
ated at 24 h postoperatively. Patients were also contacted on
postoperative day seven to capture any block-related complica-
tions such as haematoma, infection, persistent paraesthesia or
weakness in the upper limb.
The patients, anaesthetists in charge of the patient in the op-
erating theatre, Phase 1 recovery nurses, ward nurses and the re-
search assistantmeasuring the respiratory data and collecting all
other data were blinded to the group allocation.
Sample size calculation
Based on data reported in the literature the average rate of hemi-
diaphragmatic paresis after ultrasound-guided ISBwith avolume
of 20 ml was 100%.6 Assuming a 50% reduction rate, an alpha
error of 0.05 and a power of 80%, we calculated that 16 patients
would be required for each group (total 32) in order to detect a dif-
ference. Allowing for a 20% drop-out rate, we planned to recruit a
total of 40 subjects.
Statistical analysis
Data were analysed on an intention-to-treat basis. Categorical
variables are presented as frequencies and continuous variables
Fig 1 Ultrasound-guided interscalene brachial plexus block with an
extrafascial injection: needle tip position () at a distance of 4 mm from
the lateral border of the brachial plexus sheath. C5, C5 root; C6, C6 root;
C7, C7 root; ASM, anterior scalene muscle; MSM, middle scalene muscle;
nPh, phrenic nerve; SCMM, sternocleidomastoid muscle.
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are summarized as mean values with 95% conﬁdence intervals
(95% CI). Continuous parametric and non-parametric data were
compared using the Student’s t-test and Mann–Whitney U-test,
respectively. Categorical and dichotomous data were compared
using the Fisher’s exact test or Pearson test as appropriate.
Kaplan-Meier table analysis (survival analysis) was performed
for effect of localization of injection on time to ﬁrst opioid re-
quest. Signiﬁcance was considered at P<0.05 based on a two-
tailed probability. Statistical analysis was performed using the
JMP 9 statistical package (SAS Institute, Cary, NC).
Results
Forty patients were recruited and 39 completed the study for the
primary outcome. As a result of operating theatre time con-
straints, the hemidiaphragmatic excursion in one patient in the
extrafascial injection group was not visualized after the intersca-
lene brachial plexus block. All patients in both groups had a suc-
cessful block 30 min after the injection. Figure 2 depicts the ﬂow
chart of patients and Table 1 presents patients characteristics.
The rate of hemidiaphragmatic paresis was signiﬁcantly re-
duced in the extrafascial injection group (21% [95% CI: 6–46%])
compared with the conventional injection group (90% [95% CI:
68–99%]; P<0.0001). Six patients in the conventional injection
group complained of dyspnoea requiring no speciﬁc treatment
and none in the extrafascial group (P<0.01). All other respiratory
outcomes were signiﬁcantly preserved in the extrafascial injec-
tion group (Table 2).
A conventional injection was associated with a faster onset of
sensory and motor block, along with increased rates of paraes-
thesia during the procedure and hoarseness 30 min after the
procedure (Table 3). There were no differences in the other
block-related outcomes (Table 3).
The mean intraoperative fentanyl consumption was similar
between groups (conventional injection group: 158 µg [95%
CI: 142–173 µg]; extrafascial injection group: 161 µg [95% CI:
144–178 µg]; P=0.73), and the mean time to ﬁrst opioid request
(conventional injection group: 802 min [95% CI: 620–984 min];
extrafascial injection group: 973 min [95% CI: 791–1155 min];
P=0.19; Fig. 3). Other acute pain-related outcomes were similar
between groups (Table 3). No patients developed haematoma,
infection, persistent paraesthesia or weakness in the upper
limb seven days after the regional procedure.
Discussion
This double-blinded randomized controlled trial suggests
that an extrafascial injection signiﬁcantly reduces the rate of
Assessed for eligibility
(n=51)
Randomized
(n=40)
Excluded (n=11)
• Did not meet inclusion criteria (n=8)
• Surgery cancelled (n=0)
• Refused participation (n=1)
• Other reasons (n=1)
Extrafascial injection group (n=20)
• Received allocated intervention
(n=20)
• Did not receive allocated intervention 
(n=0)
Extrafascial injection group (n=20)
• Intention-to-treat analysis for the
primary outcome only (n=19)
• Excluded from analysis for the
primary outcome only (n=1)A
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Extrafascial injection group (n=20)
• Lost to follow-up (n=1)
•  Discontinued intervention (n=0)
Conventional injection group (n=20)
• Intention-to-treat analysis (n=20)
• Excluded from analysis (n=0)
Conventional injection group (n=20)
• Lost to follow-up (n=0)
•  Discontinued intervention (n=0)
Conventional injection group (n=20)
• Received allocated intervention
(n=20)
• Did not receive allocated intervention 
(n=0)
Fig 2 Flow chart of patients.
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hemidiaphragmatic paresis and impact on respiratory function,
while providing similar analgesia compared with a conventional
injection for US-guided ISB. Prolonged onset times of sensory
andmotor blocks in the extrafascial injection group are insigniﬁ-
cant for analgesic purposes and offset by increased rate of
paraesthesia and hoarseness, while groups are equally satisﬁed
with analgesia.
Previous attempts at reducing the rate of hemidiaphragmatic
paresis associated with US-guided ISB have focused on reducing
the volume of local anaesthetic injected inside the brachial
Table 2 Respiratory-related outcomes. Data are presented as mean and 95% conﬁdence interval
Conventional injection Extrafascial injection P value
Pre-procedure
Forced vital capacity (L) 4.4 (3.9–5.0) 4.6 (4.3–4.9) 0.47
Forced expiratory volume in 1 s (L) 3.5 (3.1–3.9) 3.7 (3.4–4.0) 0.39
Peak expiratory ﬂow (L s−1) 8.1 (6.9–9.2) 8.3 (7.5–9.1) 0.73
Post-procedure
Forced vital capacity (L) 3.2 (2.7–3.7) 3.8 (3.5–4.2) 0.04
Forced expiratory volume in 1 s (L) 2.6 (2.1–3.0) 3.1 (2.8–3.4) 0.02
Peak expiratory ﬂow (L s−1) 6.0 (5.0–7.0) 7.6 (6.7–8.5) 0.02
Percentage reduction
Forced vital capacity (%) 28 (33–23) 17 (22–13) <0.01
Forced expiratory volume in 1 s (%) 28 (33–22) 16 (20–12) <0.01
Peak expiratory ﬂow (%) 24 (34–15) 8 (13–3) <0.01
Table 3 Block- and acute pain-related outcomes. Data are presented as mean and 95% conﬁdence interval. NRS, Numeric Rating Scale
Conventional injection Extrafascial injection P value
Block-related outcomes
Onset time of sensory block (min) 12 (8–15) 19 (16–22) <0.01
Onset time of motor block (min) 8 (5–11) 17 (13–21) <0.001
Paraesthesia during the procedure (rate of) 30% (12–54%) 0% <0.01
Hoarseness (rate of) 35% (15–59%) 5% (0–25%) 0.02
Claude-Bernard-Horner syndrome (rate of) 35% (15–59%) 20% (6–44%) 0.29
Duration of sensory block (min) 1026 (769–1284) 922 (778–1065) 0.46
Duration of motor block (min) 1134 (892–1376) 980 (851–1109) 0.25
Acute pain-related outcomes
i.v. morphine consumption in phase I recovery (mg) 1 (0–2) 0 (0–1) 0.22
Pain scores in phase I recovery (NRS, 0–10) 0.5 (0.0–0.9) 0.4 (0.0–0.7) 0.73
Cumulative i.v.morphine equivalent consumption at 24 h postoperatively (mg) 8 (6–11) 7 (4–10) 0.48
Pain scores at 24 h postoperatively (NRS, 0–10) 1.6 (0.9–2.2) 1.6 (0.8–2.4) 0.97
Satisfaction score (NRS, 0–10) 9.5 (9.1–9.9) 9.3 (8.5–10.0) 0.58
Table 1 Patients characteristics and clinical data presented as mean (95% conﬁdence interval) standard deviations or absolute number as
appropriate
Conventional injection Extrafascial injection P value
Gender (male/female) 15/5 19/1 0.08
Age (yr) 35 (27–43) 37 (30–44) 0.64
Height (cm) 173 ± 8 177 ± 6 0.10
Weight (kg) 83 ± 16 77 ± 11 0.19
ASA (I/II/III) 6/12/2 13/6/1 0.09
Duration of surgery (min) 95 (80–111) 115 (100–130) 0.06
Surgical procedure 0.49
Shoulder joint capsular stabilization 8 8
Acromioclavicular resection 3 3
Biceps tenotomy 5 4
Open reduction - internal ﬁxation of the clavicle 2 5
Other 2 0
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plexus sheath. Investigators have reported that reducing the vol-
ume of local anaesthetic from 20 to 10ml or 5ml reduced the rate
of hemidiaphragmatic paresis to 93%7 or 45%,6 respectively. In
the present study, we were able to reduce the rate of hemidiaph-
ragmatic paresis to 21% by injecting outside of the brachial plexus
sheath without compromising analgesia. The concept of an ex-
trafascial injection can be easily translated into clinical practice
by respecting a short distance between the needle tip and the lat-
eral border of the brachial plexus, while ensuring that the local
anaesthetic injectate spreads towards the nerve roots.
The present study is subject to several limitations. First, our re-
sults cannot be used to predict which patients are at risk to de-
velop hemidiaphragmatic paresis despite an extrafascial
injection. As this is an important consideration when performing
ISB in the presence of pre-existing lung disease, our next endeav-
our is to deﬁne the anatomical and other patient-related charac-
teristics that may lead to phrenic nerve block after extrafascial
injection. Another limitation of this study is that hemidiaphrag-
matic excursion was measured only 30 min after injection of
local anaesthetic, and thereforewemay have failed to capture de-
layed-onset hemidiaphragmatic paresis. We chose to measure
hemidiaphragmatic excursion at 30 min based on pertinent stud-
ies published previously.3 6 7 Further, we did not repeat ultrasono-
graphic hemidiaphragmatic assessment and respiratory tests
after ISBandwere therefore unable todeterminedurationofhemi-
diaphragmatic paresis. Next, we did not assess local muscular ef-
fects, if any, of i.m. injection within the middle scalene muscle.
While we recognize that myotoxicity of bupivacaine has been
well described when injected into extraocular muscles, and after
repeated high volume injection in other settings,19 20 the safety
of intentional or unintentional i.m. injection of local anaesthetics
in routine clinical practice has withstood the test of time. Finally,
our results are not generalizable to continuous catheter-based ISB.
In conclusion, ultrasound-guided ISB with an extrafascial in-
jection reduces rate of hemidiaphragmatic paresis and impact on
respiratory function while providing similar analgesia, when
compared with a conventional injection.
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